OQS
XENE icon

Occudo Quantitative Strategies’s Xenon Pharmaceuticals XENE Stock Holding History

Occudo Quantitative Strategies’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,975
Closed -$582K – 934
2025
Q1 		$582K Buy
16,975
+5,534
+48% +$210K 0.08% 335
2024
Q4 		$448K Buy
11,441
+630
+6% +$26K 0.08% 337
2024
Q3 		$426K Buy
+10,811
New +$436K 0.08% 326
2022
Q4 		– Sell
-7,263
Closed -$262K – 1427
2022
Q3 		$262K Sell
7,263
-3,682
-34% -$132K 0.02% 891
2022
Q2 		$333K Buy
+10,945
New +$331K 0.03% 759

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Occudo Quantitative Strategies's XENE Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of Xenon Pharmaceuticals (XENE) in Q2 2025, closing a stake of 16,975 shares — an estimated $582K sold.

Occudo Quantitative Strategies first reported a position in XENE in Q2 2022 and held it in 5 quarters. The position peaked at $582K in Q1 2025. 206 funds tracked by Wall St. Rank hold XENE as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining Xenon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 16,975 Xenon Pharmaceuticals shares in Q2 2025, an estimated $582K.
  • Occudo Quantitative Strategies first reported a position in Xenon Pharmaceuticals in Q2 2022 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Xenon Pharmaceuticals position peaked at $582K in Q1 2025.
  • 206 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.